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ABSTRACT 
 
Stoichiometry and stability of antitumor ruthenium(II)-η6-p-cymene complexes of picolinic 
acid and its 6-methyl and 6-carboxylic acid derivatives were determined by pH-
potentiometry, 1H NMR spectroscopy and UV/Vis spectrophotometry in aqueous solution in 
the presence or absence of coordinating chloride ions. The picolinates form exclusively mono-
ligand complexes in which they can coordinate via the bidentate (O,N) mode and a chloride or 
a water molecule is found at the third binding site of the ruthenium(II)-η6-p-cymene moiety 
depending on the conditions. [Ru(η6-p-cymene)(L)(H2O/Cl)] species are predominant at 
physiological pH in all studied cases. Hydrolysis of the aqua complex or the 
chlorido/hydroxido co-ligand exchange results in the formation of the mixed-hydroxido 
species [Ru(η6-p-cymene)(L)(OH)] in the basic pH range. There is no indication for the 
decomposition of the mono-ligand complexes during 24 h in the ruthenium(II)-η6-p-
cymene−picolinic acid system between pH 3 and 11; however, a slight dissociation with a low 
reaction rate was found in the other two systems leading to the appearance of the dinuclear 
trihydroxido-bridged species [Ru2(η
6-p-cymene)2(OH)3]
+ and free ligands at pH > 10. The 
replacement of the chlorido by an aqua ligand in [Ru(η6-p-cymene)(L)Cl] was also monitored 
and equilibrium constants for the exchange process were determined.  
 
 
* Corresponding author. Tel.: +36 62 544334; fax: +36 62 420505. 
E-mail address: enyedy@chem.u-szeged.hu (É. A. Enyedy).  
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1. Introduction 
 
More and more people are diagnosed with cancer and one out of four in Europe and the US 
die of cancer [1,2]. The clinical success of cis-diamminedichloridoplatinum(II), cisplatin, has 
opened new avenues in cancer treatment. Although platinum-based drugs (and other 
chemotherapeutics) have undoubtedly many beneficial properties, treatment is paralleled by 
serious adverse effects and the development of resistance phenomena, which are limiting 
factors for curative treatment [3-5]. For this reason there is an on-going demand for the 
development of novel antitumor agents. In order to reduce the toxic effects of metal-based 
anticancer agents, Pt(IV) and other metal ions, such as Au(III), Ti(IV), Ga(III), Cu(II), 
Rh(III), Ru(III/II), were used in the design of new drug molecules. Some representatives have 
already entered and finished early clinical trial phases. These include titanocene dichloride [6] 
and [tris(8-quinolinolato)gallium(III)] [7]. However, most promising metal-based anticancer 
drug candidates in clinical trials are the Ru(III) containing imidazolium trans-
[tetrachlorido(1H-imidazole)(dimethylsulfoxide-κS)ruthenate(III)] (NAMI-A) and the trans-
[tetrachloridobis(1H-indazole)ruthenate(III)] complexes KP1019 [8-10] and KP1339 [11]. 
KP1019 is efficient in colorectal carcinoma models, while NAMI-A is an antimetastatic agent 
which can affect the motility of the cancer cells [12,13]. The mode of action and the 
intracellular targets of Ru(III) complexes are not exactly known. There are many 
investigations suggesting that the intravenously injected drugs can be transported mainly by 
the serum albumin and/or transferrin in the blood plasma [14-18]. Reduction of Ru(III) 
compounds in the cytosol leads to the kinetically more labile and more reactive Ru(II) 
compounds. This is a result of the reductive atmosphere in tumours due to fast anabolic 
processes [9,19]. DNA and cellular proteins like kinases or other enzymes were suggested as 
intracellular targets [20,21]. 
More recently, organometallic pseudo octahedral “piano-stool” Ru(II)(η6-arene) 
complexes with the metal ion stabilized in +2 oxidation state by different arene-type ligands 
have shown potential for the development of anticancer agents with a wide variety of modes 
of action [21-23]. They exhibit a well-balanced lipophilic/hydrophilic character to the 
complex allowing potential intravenous administration [22]. Such Ru(II) complexes feature in 
addition to the η6-coordinated arene ligand, often a p-cymene, three available coordination 
sites. Ru(II)(η6-p-cymene) complexes are usually prepared from reaction of the chlorido-
bridged dinuclear complex [Ru(II)(η6-p-cymene)Cl2]2 with mono- or bidentate ligands. In 
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aqueous solution the dimeric chlorido-bridged complex dissociates to monomeric species and 
hydrolyzes. The chlorido ligands can be exchanged partly or completely by aqua or 
hydroxido, depending on the chloride concentration and pH value [22-25]. These hydrolysis 
products are not anticancer active [26]. By careful selection of the ligands occupying the three 
other coordination sites the kinetics and pharmacological properties of these Ru(II) complexes 
can be modulated [27]. Ru(II)(6-p-cymene) complexes formed with bidentate (O,O) donor 
ligands such as the hydroxypyrones maltol and ethyl maltol show stronger cytotoxic effects 
than the dimeric Ru(II)(6-p-cymene) derivatives [28]. Cytotoxicity can be further improved 
by using ligands with (O,N), (N,N) or (O,S) donor systems. These comprise picolinic acid, 
thiomaltol, thioallomaltol, etc. [26,29-35]. The type of chelating ligands does not only have an 
influence on the biological properties but also impacts the stability of the complex formed by 
preventing hydrolysis of the Ru(II)(6-p-cymene) organometallic fragment. Furthermore, the 
ligand can also modify the interaction with different biomolecules such as albumin, transferrin 
or various cellular proteins. Grgurić-Šipka, Gligorijević and co-workers studied the biological 
activity of Ru(II)(6-p-cymene) complexes of various pyridine derivatives and moderate-to-
low cytotoxicity was found in six tumour cell lines; although the complex of picolinic acid 
(pic) represents an enhanced antiproliferative activity [26,36]. As these complexes are 
considered as prodrugs, the knowledge of their speciation and the most plausible chemical 
forms in aqueous solution in the biologically relevant pH range is a mandatory prerequisite 
for understanding the alterations in their biological activity.  
In the present work, solution equilibria of Ru(II)(6-p-cymene) fragments with pic, 6-
methylpicolinic acid (6-Mepic) and pyridine-2,6-dicarboxylic acid (dipic) were studied (Chart 
1) by the combination of various methods such as pH-potentiometry, UV/Vis and 1H NMR 
spectroscopy in order to determine the composition and stability of complexes formed in 
aqueous solution. These stability data are compared with those of structurally related 
hydroxy(thio)pyrone complexes featuring bidentate (O,O) or (O,S) coordination modes 
investigated in earlier studies [37]. 
Chart 1 
 
2. Experimental 
 
2.1. Chemicals 
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Pic, 6-Mepic, dipic, KCl, KNO3, AgNO3, HCl, HNO3 and KOH were purchased from Sigma-
Aldrich and used without further purification. The purity of the ligands was checked and the 
exact concentrations of the ligand stock solutions were determined by pH-potentiometric 
titrations with the help of the computer program HYPERQUAD [38]. [Ru(II)(η6-p-
cymene)Cl2]2 was synthesized and purified according to a literature procedure [39]. A stock 
solution of [Ru(II)(η6-p-cymene)(Z)3] (where Z = H2O and/or Cl
−; charges are omitted for 
simplicity) was obtained by dissolving a known amount of [Ru(II)(6-p-cymene)Cl2]2 in 
water; while the stock solution of [Ru(II)(η6-p-cymene)(H2O)3](NO3)2 was obtained from a 
solution of [Ru(II)(η6-p-cymene)Cl2]2 in water after removal of chloride ions using equivalent 
amounts of AgNO3. The exact concentration of the [Ru(II)(η
6-p-cymene)(Z)3] stock solutions 
(with or without chloride) was determined with pH-potentiometric titrations employing 
literature data for [Ru(II)2(
6-p-cymene)2(OH)i] (i = 2 or 3) complexes [24,25].  
 
2.2. pH-potentiometric measurements 
The pH-potentiometric measurements for determination of the protonation constants of the 
ligands and the overall stability constants of the metal complexes were carried out at 25.0 ± 
0.1 °C in water and at an ionic strength of 0.20 M KCl (for all the systems studied) or KNO3 
(in the case of pic) in order to keep the activity coefficients constant. The titrations were 
performed with carbonate-free KOH solution. The exact concentrations of HCl, HNO3, KOH 
solutions were determined by pH-potentiometric titrations. An Orion 710A pH-meter 
equipped with a Metrohm combined electrode (type 6.0234.100) and a Metrohm 665 Dosimat 
burette were used for the pH-potentiometric measurements. The electrode system was 
calibrated to the pH = −log[H+] scale by means of blank titrations (strong acid vs. strong base: 
HCl/HNO3 vs. KOH), as suggested by Irving et al. [40]. The average water ionization 
constant, pKw, was determined as 13.76 ± 0.01 at 25.0 °C, I = 0.20 M (KCl, KNO3), which 
corresponds well to the literature [41]. The reproducibility of the titration points included in 
the calculations was within 0.005 pH. The pH-potentiometric titrations were performed in the 
pH range 2.0−11.5 and the maximum waiting time was ~15 min at each point. The initial 
volume of the samples was 10.0 mL. The ligand concentration was 2.0 mM and metal ion-to-
ligand ratios of 1:1 to 1:3 were used. The accepted fitting of the titration curves was always 
less than 10 L. Samples were degassed by bubbling purified argon through them for ca. 10 
min prior to the measurements and it was also passed over the solutions during the titrations. 
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  The computer program PSEQUAD [42] was utilized to establish the stoichiometry of 
the complexes and to calculate the overall stability constants.  MpLqHr is defined for the 
general equilibrium: 
pM + qL + rH  MpLqHr  as (MpLqHr) = [MpLqHr]/[M]
p[L]q[H]r  (1) 
where M denotes the metal moiety [Ru(II)(6-p-cymene)Z3] and L the completely 
deprotonated ligand, which is L− for pic and 6-Mepic and L2− for dipic. Literature log values 
of the various [Ru2(
6-p-cymene)2(OH)i] complexes were used in the absence and presence of 
chloride ions [24,25] and compared to data collected in the course of the experiments 
described herein. In all calculations exclusively titration data were used from experiments in 
which no precipitate was visible in the reaction mixture. 
 
2.3. UV/Vis spectrophotometric and 1H NMR measurements 
A Hewlett Packard 8452A diode array spectrophotometer was used to record the UV/Vis 
spectra in the interval 200–800 nm. The path length was 1 cm. Protonation and stability 
constants and the individual spectra of the species were calculated with the computer program 
PSEQUAD [42]. The spectrophotometric titrations were performed on samples of the ligands 
alone or with [Ru(II)6-p-cymene)(Z)3] over the pH range 2.0–11.5 at an ionic strength of 
0.20 M (KCl or KNO3) and at 25.0 ± 0.2 °C. The concentration of ligands was set constant at 
0.12 mM or 0.32 mM in chloride free system and the metal-to-ligand ratios were 1:1 and 1:2. 
UV/Vis measurements for [Ru(II)(η6-p-cymene)(Z)3]−pic systems were carried out at 1:1 
metal-to-ligand ratio by preparing individual samples in which KCl or KNO3 was partially or 
completely replaced by HCl or HNO3 and pH values, varying in the range ca. 0.8–2.0, were 
calculated from the HCl or HNO3 content.  
1H NMR studies were carried out on a Bruker Ultrashield 500 Plus instrument. 4,4-
Dimethyl-4-silapentane-1-sulfonic acid was used as an internal NMR standard. The ligands 
were dissolved in a 10% (v/v) D2O/H2O mixture to yield a concentration of 1 mM and were 
titrated at 25 °C and I = 0.20 M (KCl, KNO3) in absence or presence of [Ru(II)(η
6-p-
cymene)(Z)3] at 1:1 and 1:2 metal-to-ligand ratios. During the 
1H NMR titrations the 
maximum waiting time was ~30 min at each point, however in case of some samples spectra 
were recorded after 24 h as well. Samples contained [Ru(II)(η6-p-cymene)(Z)3] and the pic 
ligand at various ratios (1:1−1:4) at constant concentration of the ligand (2×10−3 M) at pH 3.2. 
The 1H NMR spectra were recorded to study the H2O/Cl
− exchange processes in the 
[Ru(II)(η6-p-cymene)(L)Z] complexes at pH 3.2 (pic and dipic) and at pH 4.3 (6-Mepic) in 
6 
 
dependence of the Cl− concentration (0−500 mM). Protonation and stability constants were 
calculated with the computer program PSEQUAD [42]. 
 
3. Results and discussion 
 
3.1. Proton dissociation processes of the ligands 
The ligands chosen for these studies are derived from 2-picolinic acid (Chart 1). Their 
pKa values as determined by pH-potentiometry and 
1H NMR spectroscopy are in reasonably 
good agreement with those reported in literature (Tables 1 and S1) [43-45]. 
Table 1 
 
3.2. Complex equilibria of Ru(II)(η6-p-cymene) with picolinic acid in chloride-free medium 
The complex formation processes of pic with [Ru(II)(η6-p-cymene)(H2O)3]
2+ were studied by 
pH-potentiometry, UV/Vis spectrophotometry and 1H NMR spectroscopy in the presence of 
0.2 M KNO3. The hydrolytic equilibrium of the organometallic moiety establishes quickly in 
the absence of chloride ions in a quite simple manner. The stability constant of the dinuclear 
hydrolysis product [Ru(II)2(
6-p-cymene)2(OH)3]
+ was determined by pH-potentiometric and 
UV/Vis titrations of [Ru(II)(6-p-cymene)(H2O)3]
2+ and log (M2H−3) = −9.36(2) and 
−9.33(2) were calculated (see Table 1), respectively, which are in good agreement with data 
obtained by Buglyó et al. [25]. Analysis of the pH-potentiometric titration curves indicates 
that complex formation with pic is almost complete at the beginning of the titration at pH ~2. 
Therefore, the stability constant of [Ru(II)(6-p-cymene)(L)(H2O)]
+ (denoted [ML]+) was 
determined by pH-dependent UV/Vis measurements in the pH range of 0.8–2 (Table 1). 
Individual samples were prepared, in which KNO3 was partially or completely replaced by 
HNO3 keeping the ionic strength constant and the actual pH was calculated based on the 
strong acid content (Fig. S1). The log value of species [ML]+ was kept constant during the 
calculation of the stability constant of complex [MLH−1] from the pH-potentiometric data 
(Table 1). In addition, UV/Vis spectra were collected in the pH range 2–11 (Fig. S1) and the 
log value of species [MLH−1] was also calculated from the spectral changes. The stability 
constants of species [MLH−1] obtained by both methods are in good agreement with each 
other. Furthermore, these results were complemented by 1H NMR titrations. Due to the slow 
ligand exchange processes with respect to the NMR time scale (t1/2(obs) > ~1 ms), the 
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chemical shifts of the protons of the free and bound ligand and the [Ru(II)(η6-p-cymene)] 
fragment are clearly distinguishable in the spectra (Fig. 1). 
Fig. 1 
1H NMR spectra measured at 1:1 metal-to-ligand ratio at various pH values show the same 
picture about the speciation as the other two methods. Only one kind of complex, [ML]+, 
predominates between pH 2.5 and 6.0 and there are no signals belonging to the non-bound 
ligand or to [Ru(II)(η6-p-cymene)(H2O)3]
2+. At pH > ~ 7 the hydrolysis of the complex [ML]+ 
results in a gradually upfield shift of all peaks. The pK of the deprotonation of species [ML]+ 
was estimated on basis of the pH-dependent shifts of the signals in the 1H NMR spectra, and 
the value calculated (Table 1) is similar to that obtained by the pH-potentiometric and UV/Vis 
measurements. The distribution diagram calculated with the help of the log values of [ML]+ 
and [MLH−1] shows that the decrease of the molar fraction of species [ML]
+ correlates well 
with the change of the chemical shifts of the CH(5) signal of the coordinated ligand due to the 
deprotonation (Fig. S2). It is noteworthy that the signals of the Ar(CH) protons of p-cymene 
moiety appear in four doublets instead of the two signals expected. Most probably Ru(II) can 
act as a chirality centre which results in the existence of two conformational isomers of the 
complexes in which the unsymmetrical bidentate ligand is coordinated [46,47], altough the 
intesity ratio of the doublets is changing by increasing pH as the ratio of the isomers is 
changing possibly.   
In the complex [ML]+ the bidentate (O,N) coordination mode of pic is the most 
probable in solution, as also suggested by a single-crystal X-ray diffraction study on the 
complex in the solid phase [48], and a water molecule probably occupies the last free site at 
the [Ru(II)(η6-p-cymene)] fragment. The composition of [MLH−1] corresponds to a mixed 
hydroxido [ML(OH)] species formed by deprotonation of the coordinated water molecule of 
[ML]+.  
Partial decomposition of the complexes [ML]+ and [MLH−1] formed in the [Ru(II)(η
6-
p-cymene)]−pic system could be expected at high pH values, although the 1H NMR spectra 
clearly show the absence of the trihydroxido dimeric complex [M2H−3]
+ and the 
uncoordinated ligand in the basic pH range even after 24 h (Figs. 1 and S3). The slow 
dissociation of the complex [ML]+ was similar to that of hydroxypyridone complexes [49], for 
which however to a significant degree formation of the hydroxido-bridged dimer [M2H−3]
+ 
was detected. This was observed for Ru(II)(η6-p-cymene) complexes of hydroxypyrones such 
as ethyl maltol [37] and maltol [49] at pH > 8.8 and already at pH 7.4, respectively in the mM 
concentration range in chloride-free medium.  
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3.3. Solution equilibria of Ru(II)(η6-p-cymene) complexes of picolinic acid, 6-methyl picolinic 
acid and 2,6-dipicolinic acid in the presence of chloride ions 
Chloride ions as competitive ligands are expected to affect the stabilities of Ru(II)(η6-p-
cymene)−pyridinecarboxylate complexes in aqueous solution, as it was also shown for 
hydroxypyrones [37]. The proton displacement from the ligands pic, 6-Mepic and dipic by the 
organometallic moiety is already significant at pH 2 (representative titration curves for dipic 
are shown in Fig. 2), but to a lesser extent compared with chloride-free medium. This is 
related to the ability of chloride ions to slightly suppress complexation. Thus, the log values 
determined in the presence of chloride ions are regarded as conditional stability constants and 
are valid only under the given conditions (0.2 M (KCl), T = 25.0 °C) owing to possible 
water/chlorido co-ligand exchange in the species [Ru(II)(η6-p-cymene)Z3] (denoted as M) and 
[Ru(II)(η6-p-cymene)(L)Z] (denoted as [ML]; Z = H2O or Cl
− and the charges of the 
complexes were omitted for simplicity).  
Fig. 2 
As the complex formation takes place already in the strongly acidic pH range in the three 
studied systems, the stability constants of species [ML] of pic, 6-Mepic and dipic (Table 1) 
were determined by deconvolution of the pH-dependent UV/Vis spectra (measured at pH 0.8–
5.0). Spectra at pH < 2 were recorded for individual samples in which the KCl was partially 
or completely replaced by HCl and the actual pH values were calculated based on the HCl 
concentrations, while the changes of the metal-to-ligand charge-transfer (CT) and ligand 
bands were followed (see Fig. 3 for dipic). The direct comparison of the log [ML] of pic 
determined in the chloride-containing and in the chloride-free media (Table 1) clearly shows 
that the presence of chloride ions decreases the stability via the competition with the chelating 
ligand. A similar trend was observed for the analogous ethyl maltol complex [37]. Besides 
species [ML] of dipic formation of its protonated form [MLH] was also found in the strongly 
acidic pH range. The deprotonation of [MLH] takes place at pH < ~2.7, therefore, its 
pK(MLH) value could not be determined accurately by pH-potentiometric titrations. The 
stability constant of [MLH] could be fitted together with that of [ML] based on the recorded 
UV/Vis spectra (Fig. 3, Table 1), although with higher uncertainty since the whole 
deprotonation process could not be followed in the studied pH range. The deprotonation of 
[MLH] is accompanied by characteristic changes in the 1H NMR spectra of the Ru(II)(η6-p-
cymene)–dipic system recorded at 1:1 metal-to-ligand ratio (Fig. 4), where neither free ligand 
nor Ru fragment is present even at pH 1.98. The significant upfield shift of the peaks 
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belonging to the aromatic protons of the ligand in the range 1.98 < pH < 2.74 strongly 
supports the formation of species [ML] from [MLH]. In the complex [MLH] most probably 
the ligand coordinates via its (N,O) donor set, while the non-coordinating carboxyl group is 
protonated. Dipic typically coordinates tridentately (e.g. in the complexes of Zn(II) [50], 
Cu(II) [51], V(IV)O2+ [44], V(V)O2
+ [44] or Ru(II) and Ru(III) [52]), however, binding 
through only two donor atoms (carboxylate-O and Npyridine) in the [ML] complex of Ru(II)(η
6-
p-cymene) is most likely. This ligand cannot act as a flexible tripodal binder which would be 
needed for the simultaneous coordination of the three donor atoms in a complex with “piano-
stool” geometry.    
Fig. 3 
Fig. 4 
Log values of the complexes [ML] (and [MLH] in the case of dipic) were kept constant 
during the evaluation of the pH-potentiometric data and UV/Vis spectra collected in the pH 
range of 2–11.5 and log values of the species [MLH−1] were determined (Table 1). These 
complexes, which are most probably mixed hydroxido species (vide supra), can be formed by 
the deprotonation of the coordinated water molecule or by the displacement of the chlorido 
ligand by the hydroxide at the third binding site of Ru(II)(η6-p-cymene) moieties. The former 
process is accompanied by the upfield shift of the peaks of the aromatic protons of the 
coordinated ligand and p-cymene moiety at pH > 8 in the case of dipic (Fig. 4) and at pH > 7 
in the case of pic (Fig. 5) and 6-Mepic (not shown). The pH-potentiometric titration curves 
indicate unambiguously hydrolytic processes in the pH range mentioned as it can be 
concluded from the base consumption exceeding the number of dissociable protons in the 
ligands (see Fig. 2 for dipic). However, the decomposition of [ML] (or [MLH−1]) resulting in 
the trihydroxido dimeric complex [M2H−3]
+ would also contribute to the base consuming 
processes in the basic pH range.   
Fig. 5 
The 1H NMR spectra of the Ru(II)(η6-p-cymene)– pyridinecarboxylate systems recorded at 
1:1 metal-to-ligand ratio in the basic pH range reveal that the [ML] complex of pic does not 
decompose up to pH 11, as peaks assignable neither to [M2H−3]
+ nor to the non-bound ligand 
were observed (Fig. 5). Decomposition of the Ru(II)(η6-p-cymene) complexes of 6-Mepic 
(Fig. S4) and dipic (Fig. 4) is observed at a lesser extent at pH > ~10. This process is found to 
be relatively slow and could not be followed by pH-potentiometry accurately as the equilibria 
could not be reached during the time-scale of this method (max. ~15 min at each point). 
Therefore, the pH-potentiometric and UV/Vis data were evaluated only at pH < 10. It should 
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be noted that the hydroxido-bridged dimeric complex [M2H−3]
+ was not formed in the whole 
pH range studied when the ligand was added in excess, which can most probably protect the 
complex [ML] from the decomposition.  
 Comparison of the 1H NMR spectra of the Ru(II)(η6-p-cymene)–pic system recorded 
in the presence and absence of chloride ions (cf. Figs. 1 and 5) indicates that the spectra in 
KCl milieu are more complicated since additional peaks appear. All the peaks belonging to 
the complex [ML] appear in a double set with higher and lower intensities in the 1H NMR 
spectra. Careful analysis of the spectra recorded at various chloride concentrations revealed 
that these signals belong to the aqua and to the chlorido complexes with compositions of 
[Ru(II)(η6-p-cymene)(L)(H2O)] and [Ru(II)(η
6-p-cymene)(L)(Cl)], respectively, which are in 
slow exchange processes with respect to the NMR time scale. It is noteworthy that these kinds 
of species were also formed but were not distinguishable in the case of the 
hydroxypyr(id)ones due to fast exchange processes [37,53]. The integrated areas of the 
corresponding peaks of complexes [Ru(II)(η6-p-cymene)(L)(H2O)] and [Ru(II)(η
6-p-
cymene)(L)(Cl)] show at 0.2 M chloride concentration the presence of 7%, 15% and 51% 
aqua complex of pic, 6-Mepic and dipic, respectively (Figs. 4 and 5). The formation of the 
chlorido complexes of pic and 6-Mepic is more favourable compared with dipic and some 
hydroxypyr(id)ones [37,53].   
The chlorido/aqua co-ligand exchange processes in [Ru(II)(η6-p-cymene)(L)(Z)] of 
pic, 6-Mepic and dipic were investigated in detail by 1H NMR spectroscopy. The spectral 
changes of [Ru(II)(η6-p-cymene)(L)(H2O)]
+ were followed at various chloride concentrations 
at pH values at which the species [ML] predominate, i.e., pH 3.2 for pic (Fig. 6) and dipic 
(Fig. S5) and 4.0 for 6-Mepic. Due to the well-separated 1H NMR signals of the protons 
belonging to the aqua and chlorido complexes the integrated areas of the corresponding peaks 
could be calculated and converted to molar fractions. Based on the molar fractions logK* 
values were obtained (Table 1) for the following equilibrium: 
 
[Ru(II)(η6-p-cymene)(L)(H2O)] + Cl
−  [Ru(II)(η6-p-cymene)(L)(Cl)] + H2O (2)
a 
a Charges are omitted. 
  
Based on these equilibrium constants, concentration distribution curves were calculated for 
the complexes [ML] at various chloride concentrations (Fig. 7). 
Fig. 6 
Fig. 7 
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The complex of dipic has a logK* value about an order of magnitude lower than pic, 
thus, resulting in less favourable formation of the chlorido complex [Ru(II)(η6-p-
cymene)(L)Cl]. The coordination of the negatively-charged chloride ions to neutral 
[Ru(II)(η6-p-cymene)(dipic)(H2O)] with a non-coordinated carboxylate moiety seems to be 
less pronounced than to the positively charged aqua complex of pic and 6-Mepic. This finding 
may contribute to the explanation of the lower biological activity of the dipic complex 
compared with that of pic [36,48], in terms of showing higher reactivity to blood serum 
components. Such binding takes place by replacing the coordinated water molecule, while the 
neutral complex [Ru(II)(η6-p-cymene)(L)Cl] of pic remains intact to a higher degree 
facilitating crossing cell membranes. 
The pyridine-N is able to coordinate monodentately to the Ru center in absence of a 
second donor atom to act as a chelating ligand [36]. In order to exclude the possibility of the 
formation of bis-ligand Ru(II)(η6-p-cymene) complexes of the pyridinecarboxylates in which 
one of the ligands binds via the (N,O) donor set and the other monodentately, pH-dependent 
1H NMR spectra were recorded at 1:2 metal-to-ligand ratio (not shown). Indeed, only species 
already identified in the measurements at 1:1 metal-to-ligand ratio were found. Additionally, 
spectra were collected at various metal-to-ligand ratios at a pH value at which [ML] 
predominates (see Fig. S6 for pic). Peaks being assigned merely to the species in the 
equilibria (2) and (3) were found. Hence, there is no indication for bis-ligand complex 
formation.       
 
M + HL  [ML] + H+ (3) 
 
In order to compare the differences in speciation and thus in the stability of the complexes 
formed in the [Ru(II)(η6-p-cymene)]−pyridinecarboxylate systems, concentration distribution 
curves were calculated under the same conditions with the help of the log values determined 
for the species [MLH], [ML] and [MLH−1] by pH-potentiometry and UV/Vis 
spectrophotometry (Table 1, Fig. 8). The predominant formation of the species [ML] is found 
in all cases at physiological pH. The ratio of the non-bound metal ion in the acidic pH range 
follows the order of dipic < pic < 6-Mepic reflecting the stability trend of the complexes 
formed, namely dipic > pic > 6-Mepic. Taking the different basicities of these ligands into 
consideration, the log [ML] values were corrected according to the competition equilibrium 
(3) and logK’ (= logβ [ML] – pKa (HL)) derived constants were calculated (Table 1). A higher 
logK’ implies more favoured metal complex formation as compared with the protonated 
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ligand (HL). These values also indicate that the presence of methyl or an additional carboxylic 
acid functionality at the pyridine ring of pic has a distinct influence on the speciation. 6-
Mepic forms lower stability complexes, while the coordination compounds of dipic are 
somewhat more stable than that of pic. This trend was also shown for e.g. Zn(II) and V(IV)O 
complexes [45,54]. The more compact size of pic compared with that of 6-Mepic may result 
in higher stability; while the coordination of the dipic ligand in its L2− form seems to be 
advantageous over the binding of monovalent picolinate to the positively charged 
organometallic centre. 
Comparing the stabilities of Ru(II)(η6-p-cymene) complexes formed with the 
picolinates to those of bidentate (O,O) hydroxypyr(id)ones [24,53,55] or (O,S) 
hydroxythiopyr(id)ones [37] taking into consideration the different basicities of the ligands 
the following stability trend is seen: (O,S) > (O,N) > (O,O), which corresponds well to their 
order of biological activity [28,30,36,47-49].   
Fig. 8 
 
4. Conclusions 
 
The speciation of ruthenium(II)-6-p-cymene complexes of the pyridinecarboxylic acid pic 
and its derivatives dipic and 6-Mepic containing methyl or carboxylate functionalities at 
position (6) was characterized in aqueous solution via a combined approach using pH-
potentiometry, 1H NMR spectroscopy and UV/Vis spectrophotometry. These ligands form 
exclusively mono-ligand [ML] (and [MLH] in the case of dipic) complexes with high 
stabilities in which the ligands coordinate in a bidentate (O,N) fashion. Hydrolysis of these 
complexes results in the formation of the mixed-hydroxido species [ML(OH)] only in the 
basic pH range, although this process is almost negligible at physiological pH. No 
decomposition of the Ru(II)(η6-p-cymene)−pic complexes was found at pH < 11 even after 24 
h, while formation of the dinuclear trihydroxido-bridged species [Ru2(
6-p-cymene)2(OH)3]
+ 
and the liberation of the non-bound ligand in a slow reaction was detected already at pH ~10 
in the case of complexes of 6-Mepic and dipic. The Ru(II)(6-p-cymene) binding ability of 
the ligands shows the following order: 6-Mepic < pic < dipic. The increased stability of the 
complexes of picolinates compared to that of the (O,O) donor hydroxypyrones may be related 
to their higher biological activity.    
13 
 
The aquation of the [Ru(II)(6-p-cymene)(L)Cl] has a strong impact on the bioactivity 
and, therefore, the Cl−/H2O co-ligand exchange process was also studied by 
1H NMR 
spectroscopy and quite similar equilibrium constants were found for the complexes of pic and 
its 6-methyl derivative, while complex [ML] of dipic has much weaker ability to retain the 
chloride at the third coordination site.  
 
Acknowledgments 
This work was supported by the Hungarian Research Foundation OTKA 103905 project and É.A. 
Enyedy gratefully acknowledges the financial support of J. Bolyai research fellowship. This research 
was realized in the frames of TÁMOP 4.2.4. A/2-11-1-2012-0001 „National Excellence Program – 
Elaborating and operating an inland student and researcher personal support system” The project was 
subsidized by the European Union and co-financed by the European Social Fund.. We thank Ms. Bella 
Bruszel for conducting some of the experiments. 
 
Appendix A. Supplementary data 
 
Table containing the chemical shifts of the HL and L ligand species, UV/Vis absorbance spectra of the 
[Ru(II)(η6-p-cymene)]−pic system, 1H NMR spectra of [Ru(II)(η6-p-cymene)(H2O)3]
2+−pic system 
(time dependence, at various metal-to-ligand ratios),  [Ru(II)(η6-p-cymene)]−6-Mepic system at pH 
10.6, Ru(II)(6-p-cymene)(H2O)3]
2+−dipic system at various chloride concentrations. 
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Table 1 
Proton dissociation constants (pKa) of pic, 6-Mepic and dipic; overall (log (MpLqHr)), stepwise 
and derived stability constants of their Ru(II)-(6-p-cymene) complexes [T = 25.0 C; I = 0.20 
M (KCl)]a 
  picb pic 6-Mepic dipic 
p
H
-m
et
ry
 
pKa (H3L) (COOH) − − − < 1 
pKa (H2L) (COOH) ~ 1 ~ 1 ~ 1 2.01(3) 
pKa (HL) (Npyridine) 5.15(1) 5.17(1) 5.82(1) 4.59(1) 
U
V
/V
is
 
log  (MLH) − − − 12.4(3) 
log  (ML) 8.90(1) 8.14(1) 7.44(1) 11.25(9) 
log  (MLH−1) 0.90(2) -0.76(2) -1.63(4) 2.40(5) 
pK (MLH) = 
log  (MLH) − log  (ML) 
− − − 1.15 
pK (ML) = 
log  (ML) − log  (MLH−1) 
8.00 8.90 9.07 8.90 
logK’ (ML) = 
log  (ML) − pKa (HL) 
3.75 2.97 1.62 4.65c 
p
H
-m
et
ry
 log  (MLH−1) 0.86(2) -0.75(2) -1.60(3) 2.27(5) 
pK (ML) = 
log  (ML) - log  (MLH−1) 
8.04 8.90 9.04 8.98 
1 H
 N
M
R
 pK (ML) 8.10 − − − 
logK* (H2O/Cl
−)d − 1.83(6) 1.45(5) 0.7(1) 
a Uncertainties (SD) are shown in parentheses for the species characterized in the present work. 
Charges are omitted for simplicity. M denotes [Ru(6-p-cymene)]. Hydrolysis products of the 
organometallic fragment: log [Ru2(
6-p-cymene)2H−2]
2+ = −6.97(2) obtained by pH-metry, 
−7.02(5) by UV/Vis and log [(Ru2(
6-p-cymene)2H−3]
+ = −11.97(1) by pH-metry, −11.68(6) by 
UV/Vis. 
b Determined at I = 0.20 M (KNO3). Hydrolysis products: log [(Ru2(
6-p-cymene)2H−3]
+ = 
−9.36(2) obtained by pH-metry and −9.33(2) by UV/Vis. 
c log  (ML) – pKa (HL) – pKa (H2L)  
d [Ru(6-p-cymene)(L)(H2O)]
+ + Cl−  [Ru(6-p-cymene)(L)(Cl)] + H2O determined at various 
total concentrations of chloride ions. 
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Legends to Figures 
 
Chart 1. Chemical formulae of the ligands in their neutral forms 
Fig. 1. Low-field regions of the 1H NMR spectra recorded for the [Ru(η6-p-
cymene)(H2O)3]
2+−pic system at the indicated pH values. Symbols: CH(6) of ligand: ● in 
[Ru(η6-p-cymene)(L)(H2O)]
+; CH(5) of ligand: ■ in [Ru(η6-p-cymene)(L)(H2O)]
+; CH(3) of 
ligand: ▲ in [Ru(η6-p-cymene)(L)(H2O)]
+; CH(4) of ligand:  in [Ru(η6-p-
cymene)(L)(H2O)]
+; Ar(CH) of p-cymene moiety: ♦ in [Ru(η6-p-cymene)(L)(H2O)]
+; [cL 
= cM = 1.0 × 10
−3 M; T = 25.0 °C; I = 0.20 M (KNO3); 10% (v/v) D2O]. 
Fig. 2. pH-Potentiometric titration curves for dipic (●) and for the [Ru(II)(η6-p-
cymene)]−dipic system at different metal-to-ligand ratios. M:L ratios:  (×) 1:1; (◊) 1:2; (-) 1:4. 
[cL = 2.0 × 10
−3 M, T = 25.0 °C, I = 0.2 M (KCl)] 
 
Fig. 3.  UV/Vis absorbance spectra of the [Ru(II)(η6-p-cymene)]−dipic system recorded in the 
pH range of 1 − 2 (solid lines) on individual samples. The inset shows the spectra of the 
ligand (dotted line) and the metal ion alone (dashed line) for comparison at pH 2 at the same 
concentrations. [cL = cM = 1.2 × 10
−4 M, T = 25.0 °C, I = 0.2 M (KCl/HCl)] 
 
Fig. 4. Low-field regions of the 1H NMR spectra recorded for the [Ru(II)(6-p-cymene)(Z)3]–
dipic system at the indicated pH values [cL = cM = 2.0 × 10
−3 M, T = 25.0 °C, I = 0.2 M (KCl), 
10% (v/v) D2O]. The inset shows the pH-dependence of the 
1H NMR chemical shifts of the 
CH(4) peaks of the ligand in the mono-ligand complexes. Symbols: CH(4) of ligand: ● in 
[ML(H2O)], ○ in [MLCl]
−; Ar(CH) of p-cymene: ♦ in [MLZ] (Z = H2O or Cl
−). 
 
Fig. 5. Low-field regions of the 1H NMR spectra recorded for the [Ru(II)(η6-p-cymene)]−pic 
system at the indicated pH values. The framed details of spectra with dashed line indicate 
where would be the Ar(CH) signals of [M2H−3]
+ in case of decomposition. Symbols: CH(6) of 
ligand: ● in [ML(H2O)]
+, ○ in [MLCl], ● in [MLH−1]; CH(5) of ligand: ■ in [ML(H2O)]
+, □ 
in [MLCl], ■ in [MLH−1]; CH(3) of ligand: ▲ in [ML(H2O)]
+,  in [MLCl], ▲ in [MLH−1]; 
CH(4) of ligand:  in [ML(H2O)]
+,  in [MLCl],  in [MLH−1]; Ar(CH) of p-cymene: ♦ in 
[ML(H2O)]
+, ◊ in [MLCl], ♦ in [MLH−1]. [cL = cM = 1.0 × 10
−3 M, T = 25.0 °C, I = 0.2 M 
(KCl), 10% (v/v) D2O] 
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Fig. 6. Low-field regions of the 1H NMR spectra recorded for the [Ru(II)(6-p-
cymene)(H2O)3]
2+−pic system at various chloride concentrations at pH 3.2. Symbols: CH(6) 
of ligand: ● in [ML(H2O)]
+, ○ in [MLCl]; CH(5) of ligand: ■ in [ML(H2O)]
+, □ in [MLCl]; 
CH(3) of ligand: ▲ in [ML(H2O)]
+,  in [MLCl]; CH(4) of ligand:  in [ML(H2O)]
+,  in 
[MLCl]; Ar(CH) of p-cymene: ♦ in [ML(H2O)]
+, ◊ in [MLCl]. [cL = cM = 2.0 × 10
-3 M; T = 
25.0 °C, 10% D2O] 
Fig. 7. Concentration of distribution curves of the [Ru(II)(η6-p-cymene)]−(N,O) ligand 
systems on the basis of logK* values (pic (continuous lines), 6-Mepic (dashed lines), dipic 
(dotted lines)). [pH = 3.2 (pic, dipic); 4.0 (6-Mepic); c[ML] = 1.0 × 10
−3 M; T = 25.0 °C] 
 
Fig. 8. Concentration distribution curves for [Ru(II)(η6-p-cymene)]−pic (continuous black 
lines); [Ru(II)(η6-p-cymene)]−6-Mepic (dashed black lines) and [Ru(II)(η6-p-cymene)]−dipic 
(dotted grey lines) systems. [cL = cM = 2.0 × 10
−3 M, T = 25.0 °C, I = 0.2 M (KCl)] 
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